Doha claims victory after Saudi-led group files complaint against Qatar human rights body, aljazeera.com reported.
The Global Alliance of National Human Rights Institutions (GANHRI) has rejected a request by Saudi Arabia, Bahrain, UAE, and Egypt to get Qatar's National Human Rights Committee (NHRC) downgraded, according to NHRC chairman Ali bin Samikh al-Marri.
Marri thanked GANHRI for supporting the work of the NHRC and urged civil society groups in the four countries to work with the committee to address the worsening humanitarian conditions imposed on GCC citizens due to the measures against Qatar.
Earlier in August, the four countries, which have cut ties with Qatar and imposed a land, sea and air embargo against it, had submitted a complaint against NHRC to the United Nations High Commissioner for Human Rights in a bid to have the committee removed from the "A" rating of the GANHRI list.
Last Monday, several international human rights groups sent a letter to the UNHCR, asking them to reject the four countries' move.
"As human rights organisations, we call upon your esteemed office to reject this complaint, we also hope that you will call on the four countries, through their permanent representatives at the UN headquarters in Geneva, to stop harassment on human rights defenders, and work to upgrade their national bodies, so as to work efficiently to defend the human and his rights, in accordance with international standards in this regard, and to unite to promote human rights in the region especially and in the world in general," said the letter.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Caution urged during Ride of Champions
Ooredoo launches Voice over LTE for iPhones
Masraf Al Rayan holds blood donation campaign
German FM hopeful of overcoming Gulf rifts
Thundery rain, strong winds forecast for Wednesday
5mn Turkish products to be available online in Qatar
Dishing up a treat at Asean Food Festival
Ras Laffan hospital, health centre handed over to HMC
Novel method for personalised diagnosis of blood cancer